Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Journal of Medical Genetics
|
June 26, 2025
Long-read DNA and RNA sequencing for inherited polyposis and colorectal cancer: cryptic intronic variants and multiple mutational mechanisms
Angela L Jacobson, Amal AbuRayyan, Suleyman Gulsuner, et al.
Acta Pharmacologica Sinica
|
November 4, 2024
Intestinal human carboxylesterase 2 (CES2) expression rescues drug metabolism and most metabolic syndrome phenotypes in global Ces2 cluster knockout mice
Yao-Geng Wang, Chang-Pei Gan, Joke Beukers-Korver, et al.
Cell Reports
|
May 28, 2020
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
Michael D Nyquist, Alexandra Corella, Ilsa Coleman, et al.
Acta Pharmaceutica Sinica. B
|
March 6, 2023
Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism
Changpei Gan, Jing Wang, Alejandra Martínez-Chávez, et al.
The Journal of Clinical Investigation
|
April 17, 2012
Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer
Karim Nacerddine, Jean-Bernard Beaudry, Vasudeva Ginjala, et al.
The Journal of Clinical Investigation
|
September 16, 2025
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology
Arnab Bose, Armand Bankhead, Ilsa Coleman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 2015
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
Linda Henneman, Martine H van Miltenburg, Ewa M Michalak, et al.
Cell Reports
|
December 30, 2020
USP15 Deubiquitinase Safeguards Hematopoiesis and Genome Integrity in Hematopoietic Stem Cells and Leukemia Cells
Paul van den Berk, Cesare Lancini, Carlos Company, et al.
Genes & Development
|
June 25, 2016
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
Stefano Annunziato, Sjors M Kas, Micha Nethe, et al.
Biorxiv : the Preprint Server for Biology
|
July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
Sander Frank, Thomas Persse, Ilsa Coleman, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Journal of Medical Genetics
|
June 26, 2025
Long-read DNA and RNA sequencing for inherited polyposis and colorectal cancer: cryptic intronic variants and multiple mutational mechanisms
Angela L Jacobson, Amal AbuRayyan, Suleyman Gulsuner, et al.
Acta Pharmacologica Sinica
|
November 4, 2024
Intestinal human carboxylesterase 2 (CES2) expression rescues drug metabolism and most metabolic syndrome phenotypes in global Ces2 cluster knockout mice
Yao-Geng Wang, Chang-Pei Gan, Joke Beukers-Korver, et al.
Cell Reports
|
May 28, 2020
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
Michael D Nyquist, Alexandra Corella, Ilsa Coleman, et al.
Acta Pharmaceutica Sinica. B
|
March 6, 2023
Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism
Changpei Gan, Jing Wang, Alejandra Martínez-Chávez, et al.
The Journal of Clinical Investigation
|
April 17, 2012
Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer
Karim Nacerddine, Jean-Bernard Beaudry, Vasudeva Ginjala, et al.
The Journal of Clinical Investigation
|
September 16, 2025
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology
Arnab Bose, Armand Bankhead, Ilsa Coleman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 2015
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
Linda Henneman, Martine H van Miltenburg, Ewa M Michalak, et al.
Cell Reports
|
December 30, 2020
USP15 Deubiquitinase Safeguards Hematopoiesis and Genome Integrity in Hematopoietic Stem Cells and Leukemia Cells
Paul van den Berk, Cesare Lancini, Carlos Company, et al.
Genes & Development
|
June 25, 2016
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
Stefano Annunziato, Sjors M Kas, Micha Nethe, et al.
Biorxiv : the Preprint Server for Biology
|
July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
Sander Frank, Thomas Persse, Ilsa Coleman, et al.
Page
of 10